Why was it approved in the first place? Your guess is as good as mine. Money, probably. The cost for a year's treatment is $100,000, and it is covered by medicare. How's that for a bailout? That bailout of course is for the pharmaceutical companies. Genetech, and a bunch of patients, are lobbying hard to keep the drug as an option. Genetech says it does work, when combined with traditional chemo, and so is appealing the FDA decision. I wonder how much cashola the FDA will get back during the appeals process. The FDA approval happened while studies were in progress to prove its efficacy--but those studies turned out to prove no such thing.